Skip to main content

Advertisement

Log in

Genetic variations in estrogen and progesterone pathway genes in preeclampsia patients and controls in Bavaria

  • Maternal-Fetal Medicine
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

Hypertensive pregnancy disorders and preeclampsia are major causes of maternal and fetal morbidity and mortality worldwide. Many different organs are involved in the diseases’ clinical phenotype. The underlying mechanism is still unknown, with a possible genetic component. This case–control study investigated effects on the risk of preeclampsia of genetic variations (single nucleotide polymorphisms, SNPs) in the estrogen and progesterone pathway genes.

Methods

The study included 167 patients with preeclampsia and 115 healthy controls from the “Franconian Maternal Health Evaluation Studies” (FRAMES). All patients completed an epidemiological questionnaire, data from which were correlated with prospective data on pregnancy and labor. DNA was isolated from blood samples and genotyping was done by PCR. Variants in the aromatase gene CYP19A1 (rs10046, rs4646), progesterone receptor gene (rs1042838, rs10895068), and estrogen receptor-α gene (rs488133) were examined, and the genotype distribution in the two groups was analyzed statistically.

Results

A significant difference in the distribution frequency of genotypes between preeclampsia patients and controls was identified in one of the five SNPs. For rs10895068 in the progesterone receptor gene, genotype G/A was significantly more frequent among cases than controls (P = 0.023). No significant differences between the two cohorts were found in the other SNPs.

Conclusions

This study showed a significant association between only one SNP in the progesterone receptor and preeclampsia. Other studies have also noted genetic aspects of preeclampsia. The underlying mechanism and causal relationship are not yet known, and further research is needed to explain the extent of genetic variations and the causal relationship in preeclampsia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. American College of Obstetrics and Gynecologists Tffhip (2013) Hypertension in pregnancy. American College of Obstetrics and Gynecologists, Washington, DC (issuing body II tiltle)

  2. Steegers EAP, von Dadelszen P, Duvekot JJ, Pijnenborg R (2010) Pre-eclampsia. Lancet 376:631–644. https://doi.org/10.1016/S0140-6736(10)60279-6

    Article  PubMed  Google Scholar 

  3. Duley L (2009) The global impact of pre-eclampsia and eclampsia. Semin Perinatol 33:130–137. https://doi.org/10.1053/j.semperi.2009.02.010

    Article  PubMed  Google Scholar 

  4. Roberts JM, Gammill HS (2005) Preeclampsia: recent insights. Hypertension 46:1243–1249. https://doi.org/10.1161/01.HYP.0000188408.49896.c5

    Article  CAS  PubMed  Google Scholar 

  5. Lisonkova S, Joseph KS (2013) Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol 209(6):544 e541–544 e512. https://doi.org/10.1016/j.ajog.2013.08.019

    Article  Google Scholar 

  6. Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R (2014) Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol 10(8):466–480. https://doi.org/10.1038/nrneph.2014.102

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Hasdemir PS, Farasat M, Aydin C, Ozyurt BC, Guvenal T, Pekindil G (2016) The role of adenomyosis in the pathogenesis of preeclampsia. Geburtshilfe Frauenheilkd 76(8):882–887. https://doi.org/10.1055/s-0042-107080

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Elliot GTJ (1873) Case 120: puerperal eclampsia in the eighth month: extraordinary family history. Obstetrical Clinic. Appleton, New York

  9. Chesley LC, Annitto JE, Cosgrove RA (1968) The familial factor in toxemia of pregnancy. Obstet Gynecol 32:303–311

    CAS  PubMed  Google Scholar 

  10. Cnattingius S, Reilly M, Pawitan Y, Lichtenstein P (2004) Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: a population-based Swedish cohort study. Am J Med Genet Part A 130A(4):365–371. https://doi.org/10.1002/ajmg.a.30257

    Article  PubMed  Google Scholar 

  11. Esplin MS, Fausett MB, Fraser A, Kerber R, Mineau G et al (2001) Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med 344(12):867–872. https://doi.org/10.1056/NEJM200103223441201

    Article  CAS  PubMed  Google Scholar 

  12. Galaviz-Hernandez C, Arambula-Meraz E, Medina-Bastidas D, Sosa-Macias M, Lazalde-Ramos BP et al (2016) The paternal polymorphism rs5370 in the EDN1 gene decreases the risk of preeclampsia. Pregnancy Hypertens 6(4):327–332. https://doi.org/10.1016/j.preghy.2016.07.002

    Article  PubMed  Google Scholar 

  13. Hertig A, Liere P, Chabbert-Buffet N, Fort J, Pianos A et al (2010) Steroid profiling in preeclamptic women: evidence for aromatase deficiency. Am J Obstet Gynecol 203:477.e471–479. https://doi.org/10.1016/j.ajog.2010.06.011

    Article  CAS  Google Scholar 

  14. Dunning AM, Healey CS, Baynes C, Maia AT, Scollen S et al (2009) Association of ESR1 gene tagging SNPs with breast cancer risk. Hum Mol Genet 18(6):1131–1139. https://doi.org/10.1093/hmg/ddn429

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Dunning AM, Michailidou K, Kuchenbaecker KB, Thompson D, French JD et al (2016) Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. Nat Genet 48(4):374–386. https://doi.org/10.1038/ng.3521

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. O'Mara TA, Glubb DM, Painter JN, Cheng T, Dennis J et al (2015) Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer. Endocr Relat Cancer 22(5):851–861. https://doi.org/10.1530/ERC-15-0319

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Wunderle M, Olmes G, Nabieva N, Haberle L, Jud SM et al (2018) Risk, prediction and prevention of hereditary breast cancer - large-scale genomic studies in times of big and smart data. Geburtshilfe Frauenheilkd 78(5):481–492. https://doi.org/10.1055/a-0603-4350

    Article  PubMed  PubMed Central  Google Scholar 

  18. Binder H, Dittrich R, Hager I, Muller A, Oeser S et al (2008) Association of FSH receptor and CYP19A1 gene variations with sterility and ovarian hyperstimulation syndrome. Reproduction 135(1):107–116. https://doi.org/10.1530/REP-07-0276

    Article  CAS  PubMed  Google Scholar 

  19. Cupisti S, Fasching PA, Ekici AB, Strissel PL, Loehberg CR et al (2009) Polymorphisms in estrogen metabolism and estrogen pathway genes and the risk of miscarriage. Arch Gynecol Obstet 280(3):395–400. https://doi.org/10.1007/s00404-009-0927-1

    Article  CAS  PubMed  Google Scholar 

  20. Fasching PA, Loehberg CR, Strissel PL, Lux MP, Bani MR et al (2008) Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients. Breast Cancer Res Treat 112(1):89–98. https://doi.org/10.1007/s10549-007-9822-2

    Article  CAS  PubMed  Google Scholar 

  21. Salamalekis E, Bakas P, Vitoratos N, Eleptheriadis M, Creatsas G (2006) Androgen levels in the third trimester of pregnancy in patients with preeclampsia. Eur J Obstet Gynecol Reprod Biol 126:16–19. https://doi.org/10.1016/j.ejogrb.2005.07.007

    Article  CAS  PubMed  Google Scholar 

  22. Mark PJ, Smith JT, Waddell BJ (2006) Placental and fetal growth retardation following partial progesterone withdrawal in rat pregnancy. Placenta 27:208–214. https://doi.org/10.1016/j.placenta.2005.01.004

    Article  CAS  PubMed  Google Scholar 

  23. Gaudet MM, Milne RL, Cox A, Camp NJ, Goode EL et al (2009) Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomark Prev 18(5):1610–1616. https://doi.org/10.1158/1055-9965.EPI-08-0745

    Article  CAS  Google Scholar 

  24. Rockwell LC, Rowe EJ, Arnson K, Jackson F, Froment A et al (2012) Worldwide distribution of allelic variation at the progesterone receptor locus and the incidence of female reproductive cancers. Am J Hum Biol 24(1):42–51. https://doi.org/10.1002/ajhb.21233

    Article  PubMed  Google Scholar 

  25. Su M-T, Lee I-W, Chen Y-C, Kuo P-L (2011) Association of progesterone receptor polymorphism with idiopathic recurrent pregnancy loss in Taiwanese Han population. J Assist Reprod Genet 28:239–243. https://doi.org/10.1007/s10815-010-9510-8

    Article  PubMed  Google Scholar 

  26. ACOG Practice Bulletin No. 202: gestational hypertension and preeclampsia (2019) Obstet Gynecol 133(1):e1–e25. https://doi.org/10.1097/aog.0000000000003018

  27. Fasching PA, Faschingbauer F, Goecke TW, Engel A, Haberle L et al (2012) Genetic variants in the tryptophan hydroxylase 2 gene (TPH2) and depression during and after pregnancy. J Psychiatr Res 46(9):1109–1117. https://doi.org/10.1016/j.jpsychires.2012.05.011

    Article  PubMed  Google Scholar 

  28. Mehta D, Quast C, Fasching PA, Seifert A, Voigt F et al (2012) The 5-HTTLPR polymorphism modulates the influence on environmental stressors on peripartum depression symptoms. J Affect Disord 136(3):1192–1197. https://doi.org/10.1016/j.jad.2011.11.042

    Article  CAS  PubMed  Google Scholar 

  29. Schneider M, Engel A, Fasching PA, Haberle L, Binder EB et al (2014) Genetic variants in the genes of the stress hormone signalling pathway and depressive symptoms during and after pregnancy. Biomed Res Int 2014:469278. https://doi.org/10.1155/2014/469278

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Oppelt P, Strissel PL, Kellermann A, Seeber S, Humeny A et al (2005) DNA sequence variations of the entire anti-Müllerian hormone (AMH) gene promoter and AMH protein expression in patients with the Mayer–Rokitanski–Küster–Hauser syndrome. Hum Reprod 20(1):149–157. https://doi.org/10.1093/humrep/deh547

    Article  CAS  PubMed  Google Scholar 

  31. Renner SP, Strick R, Fasching PA, Oeser S, Oppelt P et al (2008) Single nucleotide polymorphisms in the progesterone receptor gene and association with uterine leiomyoma tumor characteristics and disease risk. Am J Obstet Gynecol 199(6):648–649. https://doi.org/10.1016/j.ajog.2008.06.015

    Article  CAS  PubMed  Google Scholar 

  32. De Vivo I, Huggins GS, Hankinson SE, Lescault PJ, Boezen M et al (2002) A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk. Proc Natl Acad Sci USA 99(19):12263–12268. https://doi.org/10.1073/pnas.192172299

    Article  CAS  PubMed  Google Scholar 

  33. Dunning AM, Dowsett M, Healey CS, Tee L, Luben RN et al (2004) Polymorphisms associated with circulating sex hormone levels in postmenopausal women. J Natl Cancer Inst 96(12):936–945. https://doi.org/10.1093/jnci/djh167

    Article  CAS  PubMed  Google Scholar 

  34. Boyd A, Golding J, Macleod J, Lawlor DA, Fraser A et al (2013) Cohort profile: the 'children of the 90s'–the index offspring of the Avon Longitudinal Study of Parents and Children. Int J Epidemiol 42(1):111–127. https://doi.org/10.1093/ije/dys064

    Article  PubMed  Google Scholar 

  35. Fraser A, Macdonald-Wallis C, Tilling K, Boyd A, Golding J et al (2013) Cohort profile: the Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort. Int J Epidemiol 42(1):97–110. https://doi.org/10.1093/ije/dys066

    Article  PubMed  Google Scholar 

  36. Moayyeri A, Hammond CJ, Hart DJ, Spector TD (2013) The UK adult twin registry (TwinsUK resource). Twin Res Hum Genet 16(1):144–149. https://doi.org/10.1017/thg.2012.89

    Article  PubMed  Google Scholar 

  37. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29(1):308–311

    Article  CAS  Google Scholar 

  38. Di Renzo GC, Giardina I, Clerici G, Brillo E, Gerli S (2016) Progesterone in normal and pathological pregnancy. Horm Mol Bio Clin Investig 27(1):35–48. https://doi.org/10.1515/hmbci-2016-0038

    Article  CAS  Google Scholar 

  39. Graham JD, Clarke CL (1997) Physiological action of progesterone in target tissues. Endocr Rev 18(4):502–519. https://doi.org/10.1210/edrv.18.4.0308

    Article  CAS  PubMed  Google Scholar 

  40. Chaudhary S, Panda AK, Mishra DR, Mishra SK (2013) Association of +331G/A PgR polymorphism with susceptibility to female reproductive cancer: evidence from a meta-analysis. PLoS ONE 8(1):e53308. https://doi.org/10.1371/journal.pone.0053308

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Huggins GS, Wong JY, Hankinson SE, De Vivo I (2006) GATA5 activation of the progesterone receptor gene promoter in breast cancer cells is influenced by the +331G/A polymorphism. Can Res 66(3):1384–1390. https://doi.org/10.1158/0008-5472.CAN-05-2715

    Article  CAS  Google Scholar 

  42. Shimodaira M, Nakayama T, Sato I, Sato N, Izawa N et al (2012) Estrogen synthesis genes CYP19A1, HSD3B1, and HSD3B2 in hypertensive disorders of pregnancy. Endocrine 42:700–707. https://doi.org/10.1007/s12020-012-9699-7

    Article  CAS  PubMed  Google Scholar 

  43. Ramirez-Lorca R, Grilo A, Martinez-Larrad MT, Manzano L, Serrano-Hernando FJ et al (2007) Sex and body mass index specific regulation of blood pressure by CYP19A1 gene variants. Hypertension 50:884–890. https://doi.org/10.1161/HYPERTENSIONAHA.107.096263

    Article  CAS  PubMed  Google Scholar 

  44. Peter I, Shearman AM, Zucker DR, Schmid CH, Demissie S et al (2005) Variation in estrogen-related genes and cross-sectional and longitudinal blood pressure in the Framingham Heart Study. J Hypertens 23:2193–2200

    Article  CAS  Google Scholar 

  45. Mansur AdP, Nogueira CCM, Strunz CMC, Aldrighi JM, Ramires JAF (2005) Genetic polymorphisms of estrogen receptors in patients with premature coronary artery disease. Arch Med Res 36:511–517. https://doi.org/10.1016/j.arcmed.2005.04.002

    Article  CAS  Google Scholar 

  46. Tamura M, Nakayama T, Sato I, Sato N, Izawa N et al (2008) Haplotype-based case-control study of estrogen receptor alpha (ESR1) gene and pregnancy-induced hypertension. Hypertens Res 31:221–228. https://doi.org/10.1291/hypres.31.221

    Article  CAS  PubMed  Google Scholar 

  47. Molvarec A, Vér A, Fekete A, Rosta K, Derzbach L et al (2007) Association between estrogen receptor alpha (ESR1) gene polymorphisms and severe preeclampsia. Hypertens Res 30:205–211. https://doi.org/10.1291/hypres.30.205

    Article  CAS  PubMed  Google Scholar 

  48. El-Beshbishy HA, Tawfeek MA, Al-Azhary NM, Mariah RA, Habib FA et al (2015) Estrogen receptor alpha (ESR1) gene polymorphisms in pre-eclamptic Saudi patients. Pak J Med Sci 31(4):880–885. https://doi.org/10.12669/pjms.314.7541

    Article  PubMed  PubMed Central  Google Scholar 

  49. Malamitsi-Puchner A, Tziotis J, Evangelopoulos D, Fountas L, Vlachos G et al (2001) Gene analysis of the N-terminal region of the estrogen receptor alpha in preeclampsia. Steroids 66:695–700

    Article  CAS  Google Scholar 

  50. Zhang J, Bai H, Liu X, Fan P, Liu R et al (2009) Genotype distribution of estrogen receptor alpha polymorphisms in pregnant women from healthy and preeclampsia populations and its relation to blood pressure levels. Clin Chem Lab Med 47:391–397. https://doi.org/10.1515/CCLM.2009.096

    Article  CAS  PubMed  Google Scholar 

  51. Nakagawa K, Lim E, Harvey S, Miyamura J, Juarez DT (2016) Racial/ethnic disparities in the association between preeclampsia risk factors and preeclampsia among women residing in Hawaii. Matern Child Health J 20(9):1814–1824. https://doi.org/10.1007/s10995-016-1984-2

    Article  PubMed  PubMed Central  Google Scholar 

  52. Breathett K, Muhlestein D, Foraker R, Gulati M (2014) Differences in preeclampsia rates between African American and Caucasian women: trends from the National Hospital Discharge Survey. J Women's Health 23(11):886–893. https://doi.org/10.1089/jwh.2014.4749

    Article  Google Scholar 

  53. Tucker MJ, Berg CJ, Callaghan WM, Hsia J (2007) The Black-White disparity in pregnancy-related mortality from 5 conditions: differences in prevalence and case-fatality rates. Am J Public Health 97(2):247–251. https://doi.org/10.2105/AJPH.2005.072975

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors acknowledge support provided by Friedrich Alexander University of Erlangen–Nürnberg (FAU) through the funding program Open Access Publishing. The contribution of Melanie Rödl to this study was performed in partial fulfillment of the requirements for obtaining the doctoral degree “Dr. med.” Parts of the study published here were used for her doctoral thesis in the Medical Faculty of Friedrich Alexander University of Erlangen–Nuremberg.

Author information

Authors and Affiliations

Authors

Contributions

JP: manuscript writing and editing. MR: project development, data management, and manuscript writing. ABE: project development. MR: protocol development and data collection. HH: data management. JS: data analysis. AT: manuscript editing. CH: manuscript editing. MWB: project development and supervision. PAF: project development and manuscript editing. MOS: manuscript editing. ES: manuscript writing and editing.

Corresponding author

Correspondence to Eva Schwenke.

Ethics declarations

Conflict of interest

The authors hereby declare that they have no conflicts of interest in relation to the publication of this paper.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pretscher, J., Ruebner, M., Ekici, A.B. et al. Genetic variations in estrogen and progesterone pathway genes in preeclampsia patients and controls in Bavaria. Arch Gynecol Obstet 303, 897–904 (2021). https://doi.org/10.1007/s00404-020-05812-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-020-05812-y

Keywords

Navigation